FR13C0008I1 - - Google Patents

Info

Publication number
FR13C0008I1
FR13C0008I1 FR13C0008C FR13C0008I1 FR 13C0008 I1 FR13C0008 I1 FR 13C0008I1 FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 I1 FR13C0008 I1 FR 13C0008I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR13C0008(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR13C0008I1 publication Critical patent/FR13C0008I1/fr
Application granted granted Critical
Publication of FR13C0008I2 publication Critical patent/FR13C0008I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FR13C0008C 1997-12-19 2013-02-06 Derives de phosphonocephem, leur procede de preparation et leur utilisation Active FR13C0008I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19
PCT/JP1998/005709 WO1999032497A1 (fr) 1997-12-19 1998-12-17 Derives de phosphonocephem, leur procede de preparation et leur utilisation

Publications (2)

Publication Number Publication Date
FR13C0008I1 true FR13C0008I1 (sk) 2013-03-22
FR13C0008I2 FR13C0008I2 (fr) 2013-08-16

Family

ID=18417716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0008C Active FR13C0008I2 (fr) 1997-12-19 2013-02-06 Derives de phosphonocephem, leur procede de preparation et leur utilisation

Country Status (19)

Country Link
US (1) US6417175B1 (sk)
EP (2) EP1043327B1 (sk)
JP (3) JP3467418B2 (sk)
KR (1) KR100384047B1 (sk)
CN (2) CN1194980C (sk)
AT (1) ATE430155T1 (sk)
AU (1) AU1683299A (sk)
BE (1) BE2013C004I2 (sk)
CA (1) CA2314564C (sk)
CY (2) CY1109276T1 (sk)
DE (1) DE69840796D1 (sk)
DK (1) DK1043327T3 (sk)
ES (1) ES2325139T3 (sk)
FR (1) FR13C0008I2 (sk)
LU (1) LU92134I2 (sk)
NL (1) NL300568I1 (sk)
PT (1) PT1043327E (sk)
TW (1) TW473479B (sk)
WO (1) WO1999032497A1 (sk)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323759T3 (es) * 2000-08-10 2009-07-24 Takeda Pharmaceutical Company Limited Compuesto de fosfonocefem.
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101357929B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有巯基噻二唑的头孢菌素衍生物
US20090082326A1 (en) 2007-09-21 2009-03-26 Forest Laboratories Holdings Limited Soluble dosage forms containing cephem derivatives suitable for parenteral administration
US20100197650A1 (en) 2008-08-28 2010-08-05 Forest Laboratories Holdings Ltd. Compositions and methods of treatment comprising ceftaroline
US8247400B2 (en) * 2009-02-23 2012-08-21 Dedhiya Mahendra G Cephem compounds useful for the treatment of bacterial infections
MX2012003201A (es) 2009-09-21 2012-05-08 Astrazeneca Ab Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina.
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
RU2769076C2 (ru) 2011-06-17 2022-03-28 Пфайзер Анти-Инфективз Аб Способ получения гетероциклических соединений, включая транс-7-оксо-6-(сульфокси)-1,6-диазабицикло[3.2.1]октан-2-карбоксамид и его соли
EP2788361A1 (en) 2011-12-07 2014-10-15 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
US9481698B2 (en) 2012-10-19 2016-11-01 Sandoz Ag Process for preparing ceftaroline fosamil
CN102977124B (zh) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法
CN104870457B (zh) * 2012-12-20 2017-08-08 桑多斯股份公司 头孢洛林酯的新晶形
KR102428252B1 (ko) 2014-02-21 2022-08-02 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 치료적 투여용 수용성 o-카보닐 포스포르아미데이트 전구약물
CN106565784B (zh) * 2016-10-31 2019-02-26 瑞阳制药有限公司 头孢洛林酯二钠盐的纯化方法
CN110872322B (zh) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 乙酸头孢罗膦一水合物及其中间体的制备方法
CN113072567B (zh) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 一种拉氧头孢钠合成工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) * 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法
JPS5511600A (en) 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
FR2511372A1 (fr) 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine et leur preparation
JPS5931791A (ja) * 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤
US4563449A (en) 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS62238291A (ja) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd セフエム化合物および医薬として許容されるその塩
US4978663A (en) 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (ja) 1992-10-02 2004-03-31 エーザイ株式会社 ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
JP3927262B2 (ja) * 1995-07-19 2007-06-06 武田薬品工業株式会社 セフェム化合物、その製造法および抗菌組成物
JPH10265488A (ja) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd ホスフォノセフェム誘導体

Also Published As

Publication number Publication date
JP2001048893A (ja) 2001-02-20
CN1194980C (zh) 2005-03-30
CA2314564A1 (en) 1999-07-01
JPH11255772A (ja) 1999-09-21
JP2009114202A (ja) 2009-05-28
DK1043327T3 (da) 2009-08-17
KR20010015885A (ko) 2001-02-26
NL300568I2 (sk) 2016-01-18
CY2013003I2 (el) 2015-08-05
NL300568I1 (sk) 2016-01-18
ES2325139T3 (es) 2009-08-26
TW473479B (en) 2002-01-21
CN1679595B (zh) 2010-05-12
US6417175B1 (en) 2002-07-09
CA2314564C (en) 2008-11-18
FR13C0008I2 (fr) 2013-08-16
EP1043327A4 (en) 2001-12-12
ATE430155T1 (de) 2009-05-15
WO1999032497A1 (fr) 1999-07-01
CY2013003I1 (el) 2014-07-02
LU92134I2 (fr) 2013-03-18
JP3467418B2 (ja) 2003-11-17
EP1043327A1 (en) 2000-10-11
CN1282335A (zh) 2001-01-31
CN1679595A (zh) 2005-10-12
EP2080765A1 (en) 2009-07-22
EP1043327B1 (en) 2009-04-29
DE69840796D1 (de) 2009-06-10
AU1683299A (en) 1999-07-12
CY1109276T1 (el) 2014-07-02
BE2013C004I2 (en) 2018-01-29
KR100384047B1 (ko) 2003-05-14
PT1043327E (pt) 2009-07-02

Similar Documents

Publication Publication Date Title
FR13C0008I1 (sk)
IN190487B (sk)
ITMI971503A0 (sk)
CH0944937H2 (sk)
ITTO970452A0 (sk)
ITTO970357A0 (sk)
IN190292B (sk)
IN188156B (sk)
ITMI971383A0 (sk)
BE2013C047I2 (sk)
ECSDI970413S (sk)
BR9701757A (sk)
BR9700653A (sk)
IN184038B (sk)
IN185067B (sk)
IN186428B (sk)
IN186646B (sk)
IN191619B (sk)
ITPD970048V0 (sk)
ITRM970436A0 (sk)
CN3056276S (sk)
CN3054162S (sk)
CN3057613S (sk)
CN3057614S (sk)
CN3056875S (sk)